Cambridge Research Biochemicals (CRB) Ltd, a specialist in the synthesis of peptides and protein fragments for use in research, has been named as one of the partners in the Framework Programme 7 project, Bioscent.
Billingham-based CRB’s involvement is as an SME responsible for providing peptide synthesis expertise and supplying synthetic peptides. The company will be eligible for €196,400 as part of the €6.1 million, five-year project.
There are 15 European members of the consortium, which is headed by the University of Pisa, Italy.
CRB’s Commercial Director Emily Humphrys said, “To be involved is very exciting for us because it means that we are collaborating with some of the most respected research groups across Europe.”
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
